Clinical Trial Update: A Randomized Study of Sativex on Cognitive Function and Mood: Multiple Sclerosis Patients [Phase 4]

View source ↗

Summary

Phase 4 randomized trial assessing Sativex for cognitive function and mood in multiple sclerosis patients with spasticity; study completed with results posted i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis
• Spasticity

Drugs mentioned

• Sativex (nabiximol)

Snippet

Sponsor: Jazz Pharmaceuticals | Conditions: Multiple Sclerosis, Spasticity | Phase 4 | Status: COMPLETED | Results posted: 2014-05-02